- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Medicenna Therapeutics Corp (MDNAF)
Medicenna Therapeutics Corp stock price live, this page displays TSX MDNA stock exchange data. View the MDNA premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Medicenna Therapeutics Corp real time stock price chart below.
What Is the Medicenna Therapeutics Corp Stock Price Today?
The Medicenna Therapeutics Corp stock price today is 0.8000.
What Is the Stock Symbol for Medicenna Therapeutics Corp?
The stock ticker symbol for Medicenna Therapeutics Corp is MDNA.
Is MDNA the Same as $MDNA?
$MDNA is a common way to refer to the Medicenna Therapeutics Corp ticker symbol in social media, forums, and online discussions. The dollar sign is a shorthand convention used to indicate that it is a stock ticker symbol
What Stock Exchange Does Medicenna Therapeutics Corp Trade On?
Medicenna Therapeutics Corp is listed and trades on the Toronto stock exchange.
Is Medicenna Therapeutics Corp a Good Stock to Buy?
Determining whether Medicenna Therapeutics Corp—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess the current Medicenna Therapeutics Corp share price compared with the fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the MDNA quote. (ISIN: CA58490H1073)
What Is the Medicenna Therapeutics Corp Stock Price Today?
The Medicenna Therapeutics Corp stock price today is 0.8000.
What Is the Stock Symbol for Medicenna Therapeutics Corp?
The stock ticker symbol for Medicenna Therapeutics Corp is MDNA.
Is MDNA the Same as $MDNA?
$MDNA is a common way to refer to the Medicenna Therapeutics Corp ticker symbol in social media, forums, and online discussions. The dollar sign is a shorthand convention used to indicate that it is a stock ticker symbol
What Stock Exchange Does Medicenna Therapeutics Corp Trade On?
Medicenna Therapeutics Corp is listed and trades on the Toronto stock exchange.
Is Medicenna Therapeutics Corp a Good Stock to Buy?
Determining whether Medicenna Therapeutics Corp—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess the current Medicenna Therapeutics Corp share price compared with the fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the MDNA quote. (ISIN: CA58490H1073)
0.8000
+0.0402(+5.29%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.7501
0.8200
52 wk Range
0.6000
2.1740
MDNAF Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
MDNAF is not included in our AI-picked strategies. See which stocks are.
Review Strategies
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.75010.8200
52 wk Range
0.60002.1740
Key Statistics
Edit
Prev. Close
Open
Volume
Average Vol. (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Vol. (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
MDNAF Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceAnalysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Quickly burning through cash
Medicenna Therapeutics Corp Company Profile
Medicenna Therapeutics Corp., an immunotherapy company, engages in the development and commercialization of Superkines and empowered Superkines for the treatment of cancer and other diseases. It develops bizaxofusp (MDNA55), an interleukin- 4 (IL-4) EC for the treatment of recurrent glioblastoma, as well as for brain tumors. The company also develops MDNA11, an enhanced version of IL-2 to activate and proliferate the immune cells needed to fight cancer; MDNA209, an IL-2 antagonist for autoimmune diseases, such as multiple sclerosis and graft versus host disease; MDNA413, a dual IL-4/IL-13 antagonist to treat cancer immunotherapies; MDNA113, a masked bi-functional anti-PD1-IL2 Superkine for various solid tumors; and MDNA132, an IL-13 Superkine for various tumors. In addition, it provides BiSKITs platform to develop designer Superkines by fusing them to other proteins, inhibitors, antibodies, cytokines, or other Superkines Medicenna Therapeutics Corp. is headquartered in Toronto, Canada.
Compare MDNAF to Peers and Sector
Metrics to compare | MDNAF | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipMDNAFPeersSector | |
|---|---|---|---|---|
P/E Ratio | −3.5x | −2.6x | −0.5x | |
PEG Ratio | 0.06 | 0.08 | 0.00 | |
Price / Book | 5.4x | 1.0x | 2.6x | |
Price / LTM Sales | - | 2.1x | 2.9x | |
Upside (Analyst Target) | - | 170.6% | 49.4% | |
Fair Value Upside | Unlock | 6.4% | 8.2% | Unlock |
Earnings
Latest Release
Feb 13, 2025
EPS / Forecast
-0.0492 / -0.0476
Revenue / Forecast
-- / --
FAQ
What Is the Medicenna Therapeutics Corp (MDNAF) Stock Price Today?
The Medicenna Therapeutics Corp stock price today is 0.80
What Stock Exchange Does Medicenna Therapeutics Corp Trade On?
Medicenna Therapeutics Corp is listed and trades on the OTC Markets stock exchange.
What Is the Stock Symbol for Medicenna Therapeutics Corp?
The stock symbol for Medicenna Therapeutics Corp is "MDNAF."
What Is the Medicenna Therapeutics Corp Market Cap?
As of today, Medicenna Therapeutics Corp market cap is 67.47M.
What Is Medicenna Therapeutics Corp's Earnings Per Share (TTM)?
The Medicenna Therapeutics Corp EPS (TTM) is -0.36.
When Is the Next Medicenna Therapeutics Corp Earnings Date?
Medicenna Therapeutics Corp will release its next earnings report on Jun 25, 2025.
From a Technical Analysis Perspective, Is MDNAF a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Buy.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.